AirStrip, a leader in clinical surveillance, decision support, and alarm management solutions, announced the acquisition of Fifth Eye, the developer of the FDA-cleared AHI System, which is software that predicts hemodynamic instability before it becomes apparent in traditional vital signs.
The acquisition of Fifth Eye enhances AirStrip’s recent expansion efforts, including the launch of its Alarm Management middleware solution and the acquisition of DECISIO Health, a provider of critical care decision support tools. These developments together reflect AirStrip’s strategy to unify advanced analytics and clinical context into a single platform.
AHI System: The AHI System enhances clinical decision-making by analyzing non-invasive ECG signals in near real time, offering a dynamic view of a patient’s hemodynamic status. And by identifying subtle physiologic changes earlier than standard monitoring tools, AHI enables clinicians to intervene sooner, potentially preventing adverse events and improving outcomes.
AirStrip ONE: AirStrip’s portfolio is anchored by AirStrip ONE, a vendor-agnostic and HIPAA-compliant platform offering native mobile and web applications, medical device integration, and actionable surveillance. The addition of AHI strengthens this ecosystem by helping clinicians identify which patients require increased attention and which are showing improvement.
KEY QUOTES:
“This acquisition accelerates a fundamental shift in how clinical intelligence is delivered. We’re breaking down silos and equipping care teams with near real-time, predictive insights that can transform patient safety across the continuum of care.”
“AHI aligns perfectly with our mission to deliver intelligent, actionable insights to the bedside. With AHI, we’re giving clinicians a clearer picture of patient trajectory—enabling more confident and timely care decisions.”
Haris Naseem, MD, CEO of AirStrip Technologies
